Taha Qazi, MD: AGA Guideline’s Impact on Pouchitis, Inflammatory Pouch Disorder Management
Qazi discusses the impact of having standardized definitions and treatment approaches for pouchitis and inflammatory conditions of the pouch.
Read More
Taha Qazi, MD: Fenofibrate As First-Line Therapy in Primary Biliary Cholangitis
Qazi discusses a review of the use of fenofibrate as a first-line therapy in treatment-naive patients with PBC and its implications for biochemical response.
Taha Qazi, MD: Using Tofacitinib to Improve Treatment Response in Acute Severe Ulcerative Colitis
Qazi discusses tofacitinib’s role in acute severe ulcerative colitis management as a potential first-line therapy to increase treatment responsiveness.
Taha Qazi, MD: Blue-C Multi-Target Stool DNA Test, Other Noninvasive Options for CRC Screening
Qazi discusses a review of the BLUE-C trial and explains the rise of noninvasive CRC screening and surveillance options, but highlights the need for colonoscopy nonetheless.
Katie Falloon, MD: SEQUENCE and Treatment Positioning
Katie Falloon, MD, discusses findings from the SEQUENCE study, the importance of treatment positioning, and what direct data from head-to-head studies contributes to this understanding.
Shubha Bhat, PharmD: Understanding Etrasimod for Ulcerative Colitis
Shubha Bhat, PharmD, MS, BCACP describes the ELEVATE UC program supporting the FDA approval of etrasimod and the current understanding of treatment positioning between etrasimod and ozanimod.
Taha Qazi, MD: Evolving Bariatric Surgery Value in GI
Data support the benefit of bariatric surgery in patients at high risk of pancreatic ductal adenocarcinoma due to BMI and metabolic comorbidities.
Taha Qazi, MD: Addressing Smoking Cessation in the GI Office
Qazi reviews an analysis of an EHR-assisted smoking cessation module that could improve conversations between specialists and patients.
Taha Qazi, MD: Best Screening for Colorectal Cancer
While discussing a review of noninvasive options, the gastroenterologist addresses the growing interest in non-colonoscopy screening and surveillance methods.
Taha Qazi, MD: Finding Upadacitinib's Role in Crohn's Disease
Qazi reviews the selective JAK1 inhibitor's benefit for patients who previously failed TNF inhibitor regimen.
Introducing The Qazi Corner: A Gastroenterology Newsletter Featuring Taha Qazi, MD
The Qazi Corner will be a quarterly newsletter led by Taha Qazi, MD, of the Cleveland Clinic and featuring new data, conference highlights, and perspectives of leading gastroenterologists.